Benfotiamine, Explained

Vitamin B1 (thiamine), as it is found in standard vitamin supplements or obtained from the diet, is water-soluble, which means it may have inherent problems with absorption. Water-soluble vitamin B1 is dependent on specialized transporter molecules to carry it through the intestinal wall and into the bloodstream. These transporters are prone to interference, limiting how much vitamin B1 gets into the bloodstream.

Benfotiamine is a unique fat-soluble form of the vitamin that bypasses this problem entirely. Because of its fat-soluble nature, benfotiamine passes through the intestinal wall without needing transporters, allowing the body to absorb it far more efficiently. Once absorbed, it is converted from its fat-soluble form into water-soluble thiamine, the active form the body uses. Benfotiamine is an excellent vitamin B1 delivery system, safe and highly effective, allowing significantly higher levels of vitamin B1 to enter the blood, so that all the critical functions of vitamin B1, such as energy production, mitochondrial protection, and antioxidant and anti-inflammatory processes, can be performed more efficiently.

Researchers around the world have studied benfotiamine for more than six decades, and the body of research continues to grow, particularly around nerve function, cognition, and metabolic health.

To understand why benfotiamine is so important, it helps to understand a significant problem with absorbing standard vitamin B1 supplements.

Standard vitamin B1 is water-soluble. To absorb it, the body has to actively pull it through the intestinal wall using specialized transporter molecules. This system isn’t always efficient. It is prone to interference. Many things can interfere with proper absorption:

• Age. Absorption tends to decline as the body gets older.
• Heavy alcohol use. Alcohol interferes with vitamin B1 absorption.
• Metformin. One of the most widely prescribed diabetes medications in the world, metformin has been shown to partially block thiamine from being absorbed through the intestinal wall, meaning diabetics, the very people who are at greatest risk of vitamin B1 deficiency, are taking a medication that blocks its absorption. Benfotiamine can bypass this problem entirely.
• Other medications that block thiamine absorption. Loop diuretics such as furosemide, proton pump inhibitors such as omeprazole, and hydroxychloroquine have all been shown to interfere with thiamine absorption. People taking any of these medications may be absorbing significantly less thiamine than they realize.

Many people may be functionally deficient in vitamin B1 even when they believe they are getting adequate amounts through their diet and supplementation. This is particularly true of diabetics. Vitamin B1 processing issues may also be associated with alcoholism, Alzheimer’s disease, Parkinson’s disease, and COVID-19. Click here for more information on this and to see the work published by researchers on this topic.

Benfotiamine is specifically designed to solve the problem of functional vitamin B1 deficiency. Because it is fat-soluble, it passes through the intestinal wall on its own, without needing the transporters. Pharmacokinetic research from Loew (1996) showed that the same dose of benfotiamine raises vitamin B1 in the body several times higher than an equivalent dose of standard vitamin B1.

Vitamin B1 is one of the body’s foundational nutrients. Two of its biggest jobs:

• Energy. Vitamin B1 helps cells convert food into ATP, the molecule the body uses as its main energy currency. Every cell needs it, and nerve cells and brain cells are especially dependent on it because they are metabolically demanding.
• Nerve function. Vitamin B1 supports the chemistry that allows nerves to fire and communicate properly.

When vitamin B1 is low, the systems that lean on it the hardest tend to feel it first. That is part of why researchers have looked at benfotiamine in connection with nerve and brain health.

Once benfotiamine reaches the bloodstream, the body converts it into the active form of vitamin B1, a molecule called thiamine pyrophosphate(TPP for short). Think of TPP as a key. Several of the body’s most important cellular machines need it before they can start working.

Two of those machines live inside mitochondria, the tiny power plants inside every cell. Together, they help run the cycle that turns food into ATP, the molecule the body uses as its main fuel. Both machines need TPP to run. When TPP is low, they slow down, and ATP production slows with them. The cells that notice the drop first are the ones with the highest energy needs: nerve cells and brain cells.

A third machine, an enzyme called transketolase, does a different kind of work. Research from Hammes and colleagues (2003) described how activating transketolase can redirect excess sugar molecules away from three pathways linked to tissue damage when blood sugar runs high. It is part of the early mechanistic work that shaped how researchers think about benfotiamine’s role in sugar-related cellular stress.

Other research has looked beyond blood sugar. Animal studies, including a 2010 paper from Pan and colleagues using an Alzheimer’s mouse model, have explored a possible role for benfotiamine in brain energy metabolism. These are early-stage findings, the kind researchers continue to follow up on.

These findings are from laboratory and animal studies, and not clinical treatment claims. They describe how benfotiamine appears to work inside cells, which is the foundation researchers have built on in the human studies referenced throughout this site.

Researchers have studied benfotiamine in connection with a range of conditions and symptoms. Below are areas where scientific literature has explored a positive relationship with Benfotiamine. This is not a list of ailments benfotiamine treats.

• Peripheral neuropathy. Burning, tingling, numbness, and pain, often in the feet and legs.
• Diabetic polyneuropathy. Nerve damage associated with diabetes and prediabetes^[4][5].
• Alcohol-related neuropathy. Nerve dysfunction associated with chronic alcohol use^[6].
• Alzheimer’s disease and cognitive decline. Studied for its role in brain energy metabolism^[3].
• Parkinson’s disease. Examined as part of broader research into how vitamin B1 works in neurological disease.
• ALS (amyotrophic lateral sclerosis). Early-stage research has explored vitamin B1 pathways in ALS.
• Long COVID brain fog. Emerging research on lingering cognitive symptoms after COVID-19.
• Restless legs syndrome (RLS). Case reports have explored a connection to vitamin B1 levels.

Benfotiamine isn’t new. It has been used and studied worldwide for more than sixty years, with a long research tradition in Europe and Asia, where it has been part of the conversation around nerve health for decades.

More recently, the English-language research base has expanded substantially. Benfotiamine has moved from a little-known European nutrient to a subject of active clinical interest in the United States.

In the published literature, benfotiamine has consistently been described as safe and well-tolerated, with no significant adverse effects reported in the research. It does not require a prescription. As with any supplement, anyone considering it should speak with a qualified healthcare provider, especially if they take other medications or manage an ongoing health condition.